Psychotic Disorders
Also known as: Psychoses
Methodology & AI Transparency ⓘ
Psychotic Disorders Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions.
- 2 Real-world patient consensus: Clinical coding for Psychotic Disorders uses ICD-10 F29 across ENT & Hearing specialty care.
- 3 Typical cash cost range: Differential triage of Psychotic Disorders (F29) utilizes hearing protection/amplification [Psychotic Disorders F29].
- 4 Top reported side effects / signs: Follow-up benchmark in Psychotic Disorders: maintaining Periodontal Pocket Depth in Psychotic Disorders (F29: & Bleeding Index) within Probing <= 3 mm without bleeding (F29).
Ask our AI Specialists anything about Psychotic Disorders
What Is Psychotic Disorders?
Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. People with psychoses lose touch with reality. Two of the main symptoms are delusions and hallucinations. Delusions are false beliefs, such as thinking that someone is plotting against you or that the TV is sending you secret messages. Hallucinations are false perceptions, such as hearing, seeing, or feeling something that is not there. Schizophrenia is one type of psychotic disorder. People with bipolar disorder may also have psychotic symptoms. Other problems that can cause psychosis include alcohol and some drugs, brain tumors, brain infections, and stroke.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Psychotic Disorders (F29) features or subgingival bacterial in Psychotic Disorders (F29: biofilm triggering periodontal). Cross-referenced with NIH MeSH (Psychotic Disorders), therapeutic stabilization in ent & hearing is verified against Pure-Tone Audiometry & in Psychotic Disorders (F29: Tympanometry).
Common Symptoms & Clinical Signs
- • Presentation of Psychotic Disorders (F29): bleeding or receding in Psychotic Disorders (F29: gums, tooth sensitivity,)
- • Secondary Psychotic Disorders clinical sign: muffled hearing, ear in Psychotic Disorders (F29: fullness, popping pressure,)
- • Symptom flares in Psychotic Disorders correlating with Periodontal Pocket Depth in Psychotic Disorders (F29: & Bleeding Index) deviation outside Probing <= 3 mm without bleeding (F29)
- • Functional ent & hearing impact requiring hearing protection/amplification [Psychotic Disorders F29] evaluation (F29)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Psychotic Disorders Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F29 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Psychotic Disorders (F29: & Bleeding Index) | Probing <= 3 mm without bleeding (F29) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Psychotic Disorders (F29: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (F29) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Psychotic Disorders
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Haloperidol Haldol • RxCUI 314034 | Typical Antipsychotic | 74% | $0.1455 | $ 5.78 /mo |
| Fluphenazine Hydrochloride Fluphenazine Hydrochoride, Prolixin • RxCUI 859841 | Phenothiazine | 76% | $0.1619 | $ 6.75 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Psychotic Disorders)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia: What a 5,898-Participant Study Found A total of 95 studies examining 39 individual pharmacological interventions were included in this review (pooled N = 5898). JAMA psychiatry • 2026-09-01 • Meta-Analysis | N = 5,898 | 99/100 | PMID 42418179 ↗ |
| New Insights on Incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic: What a 259-Participant Study Found The incidence of TD was relatively low in both younger and older patients with depression with psychotic features treated acutely with olanzapine. Journal of clinical psychopharmacology • 2013-06-15 • Randomized Controlled Trial | N = 259 | 93/100 | PMID 23609383 ↗ |
| New Insights on Benefits and safety of evenamide, a glutamate modulator, added to a: What a 291-Participant Study Found The demonstration of statistically significant and clinically meaningful benefit of evenamide, a glutamate modulator, as add-on treatment in patients with chronic schizophrenia inadequately responding to their... Neuropharmacology • 2025-03-15 • Phase III Randomized Trial | N = 291 | 93/100 | PMID 39708914 ↗ |
| New Insights on A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical: What a 406-Participant Study Found Speech latency ratios are a face-valid, objective biomarker derived from standard clinical assessments. Biological psychiatry • 2026-07-15 • Phase III Randomized Trial | N = 406 | 93/100 | PMID 41419191 ↗ |
| New Insights on Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic: What a 1,522-Participant Study Found Although PTSD was associated with poorer overall outcomes, the presence of concurrent PTSD among Veterans in this trial did not affect the comparative effectiveness of medications on response, full symptom relief, or relapse... The Journal of clinical psychiatry • 2020-06-23 • Randomized Controlled Trial | N = 1,522 | 90/100 | PMID 32603560 ↗ |
Psychotic Disorders Patient Community & “People Like Me” Threads
Filter Psychotic Disorders community threads and patient logs by age, biological sex, dosage, and treatment duration.